
Misobit 25 Tablet
Marketer
Lupin Ltd
Salt Composition
Miglitol (25mg)
Overview Misobit 25 Tablet
Glycemia Control 25mg tablets are indicated for the management of type 2 diabetes. This medication assists in regulating elevated postprandial blood glucose levels. It's prescribed when dietary modifications and other comparable treatments prove insufficient in achieving optimal glycemic control. Administer Glycemia Control 25mg just prior to or with the initial bite of a meal. Dosage frequency is determined by your physician to ensure appropriate blood sugar regulation, potentially increasing gradually. Discontinuation should only occur under medical supervision as abrupt cessation may lead to dangerously high blood glucose, increasing the risk of severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as directed by your doctor. Regular blood glucose monitoring is essential while using this medication. Commonly reported side effects include skin eruptions, flatulence, abdominal discomfort, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Glycemia Control 25mg itself does not induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your physician of any hepatic or renal dysfunction before commencing treatment. This medication is contraindicated in patients with bowel ulceration or inflammation (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating women require prior medical consultation. Always disclose all medications you are currently taking to ensure medication safety. Limit alcohol consumption to minimize the risk of hypoglycemia.
Uses of Misobit 25 Tablet
Managing type 2 diabetes
Major Benefits of Misobit 25 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Misobit 25 Tablet with a meal.
Common Side effects of Misobit 25 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Misobit 25 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Misobit 25 Tablets should be administered with a meal.
How Misobit 25 Tablet works:
Misobit 25 Tablet is an antidiabetic medication that works by blocking the activity of intestinal enzymes which digest complex carbohydrates. This action reduces postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Misobit 25 Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Misobit 25 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
Using Misobit 25 Tablet while breastfeeding is likely safe. Studies in humans indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Misobit 25 Tablet.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Misobit 25 Tablets; dosage modification may be necessary. Consult a physician before use. Misobit 25 Tablets are contraindicated in patients with severe kidney disease.
LiverSAFE IF PRESCRIBED
Use of Misobit 25 Tablet in individuals with liver impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is advised.
What if you forget to take Misobit 25 Tablet :
Omit any missed Misobit 25 Tablet dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Misobit 25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Nojirimycin Analog |
| Developing Habits | No. |
| Type of Therapy | Diabetes medication |
| Action Category | Alpha-glucosidase inhibitors |
